Fundraising Fox
AiCure
Founded 2010 · 39 employees on LinkedIn · 13 known investors
Find your way into AiCure
Sign up to see every warm intro you have to AiCure
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AiCure team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AICure is an AI-powered medication adherence platform for life sciences organizations that uses computer vision and machine learning to verify patient medication adherence and capture real-time behavioral data to improve clinical trial outcomes and patient engagement. The platform serves pharmaceutical companies, clinical trial operators, and healthcare organizations seeking objective insights into medication compliance without wearables or invasive hardware.
Founders & leadership
Investors · 13
How we know: Accelmed Partners's portfolio page · prnewswire.com · Not right? Tell us
How we know: Asahi Kasei Corporate Venture Capital's portfolio page · Not right? Tell us
How we know: Palisades Growth Capital's portfolio page · prnewswire.com · Not right? Tell us
How we know: Tribeca Venture Partners's portfolio page · prnewswire.com · Not right? Tell us
How we know: a partner's Signal profile · prnewswire.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$4M disclosed across 1 of 3 rounds · 2016–2024
- $4MraisedJan 2024 · 2 sourcesSource ↗
- Undisclosed amountSeries CNov 2019
Palisades Growth Capital (lead), Accelmed Growth Partners, Asahi Kasei Corporation, Baird Capital, Biomatics Capital, New Leaf Venture Partners, Silicon Valley Bank, Singtel Innov8, SpringRock Ventures, the Pritzker Group, Tribeca Venture Partners
Source ↗ - Undisclosed amountSeries AJan 2016Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through AiCure went on to found or lead other companies.
Non-dilutive funding · 5 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2013 | $997.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $227.2K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $137.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $273.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does AiCure do?
- AICure is an AI-powered medication adherence platform for life sciences organizations that uses computer vision and machine learning to verify patient medication adherence and capture real-time behavioral data to improve clinical trial outcomes and patient engagement. The platform serves pharmaceutical companies, clinical trial operators, and healthcare organizations seeking objective insights into medication compliance without wearables or invasive hardware.
- Who are AiCure's investors?
- AiCure's investors include VIVE VC, Accelmed Partners, Asahi Kasei Corporate Venture Capital, Palisades Growth Capital, Tribeca Venture Partners, Baird Capital, New Leaf Venture Partners, Pritzker Group Venture Capital and 2 more.
- How much funding has AiCure raised?
- AiCure has disclosed $4M raised across 1 of its 3 known rounds.